https://pubmed.ncbi.nlm.nih.gov/40215366/
Long-Term Progression-Free Survival With Sunitinib in Advanced Recurrent Adrenocortical Carcinoma
Long-Term Progression-Free Survival With Sunitinib in Advanced Recurrent Adrenocortical Carcinoma
long term
https://www.knowcancer.com/cancer-trials/NCT00694096/
Sunitinib for Metastatic Renal Cell Cancer With Imaging Biomarker Assessments for the Early...
This exploratory clinical study is designed to obtain pre-therapeutic imaging assessments in 20 evaluable patients with metastatic renal cell cancer (RC
https://www.rxlane.com/product-tag/sunitinib-capsule-philippines
Sunitinib capsule Philippines
sunitinibcapsulephilippines
https://polpharma.pl/produkty/substancje-czynne/2730/
SUNITINIB Archives - Polpharma
sunitinibarchivespolpharma
https://adisinsight.springer.com/drugsafety/803119165?error=cookies_not_supported&code=55479734-b090-48cc-9800-7393d8694eb8
Sunitinib - AdisInsight
In a retrospective study of 155 patients, aged 18 years or older, 1 patient [age and sex not stated] was identified to have developed nephrotic syndrome during
sunitinibadisinsight
https://www.irst.emr.it/it/pubblicazioni/axitinib-after-sunitinib-in-metastatic-renal-cancer-preliminary-results-from-italian-realworld-sax-study
Axitinib after Sunitinib in Metastatic Renal Cancer Preliminary Results from Italian RealWorld SAX...
Frontiers in pharmacology
https://adisinsight.springer.com/drugsafety/801026847?error=cookies_not_supported&code=03d51424-32a1-4a8f-b4ea-6c74b8b412d8
Imatinib/sunitinib - AdisInsight
A 73-year-old woman developed hypothyroidism while receiving imatinib, then sunitinib, for metastatic gastrointestinal stromal cancer.The woman was receiving
imatinibsunitinibadisinsight
https://indiangenericprice.com/old/sunitinib-sutent-cost-italy
Sunitinib (Sutent) 50 mg Cost in Italy & Compare prices
in italysunitinibsutentmgcost
https://www.ispor.org/vih-articles/Volume-18--Issue-7/Cost-Effectiveness-Of-Sunitinib-As-Second-Line-Treatment-For-Gastrointestinal-Stromal-Tumor(Gist)-In-China
Cost-Effectiveness Of Sunitinib As Second-Line Treatment For Gastrointestinal Stromal Tumor(Gist)...
https://wikidoc.org/index.php/Sunitinib_malate
Sunitinib - wikidoc
sunitinib
https://christie.openrepository.com/entities/publication/51104410-e125-4eae-a9cb-3f0cd76a21b1
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
The multitargeted tyrosine kinase inhibitor sunitinib has shown activity against pancreatic neuroendocrine tumors in preclinical models and phase 1 and 2...
sunitinib malatefor thetreatmentpancreaticneuroendocrine
https://www.pharmacompass.com/excipient-product-list/sunitinib/rochem-international-inc
Rochem International Inc | Pharmaceutical Excipients for Sunitinib
Find Rochem International Inc's pharmaceutical excipient solutions - Mannitol for Sunitinib to address your drug formulation challenges (e.g. improved...
pharmaceutical excipientsinternationalincsunitinib
https://e-crt.org/journal/view.php?number=16
Sunitinib Treatment for Metastatic Renal Cell Carcinoma in Patients with Von Hippel-Lindau Disease
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/59651-0465/
59651-0465 SUNITINIB MALATE - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
sunitinib malatendc
https://sk-pharma.com/product/sunitinib-s-k-12-5-mg/
SUNITINIB S.K 12.5 MG - SK-Pharma
Aug 21, 2025 - Explore Sunitinib S.K. 12.5 MG treatment of gastrointestinal stromal tumor and its potential benefits for patients.
s ksunitinibmgskpharma
https://alentris.org/products/s/sunitinib/sunitinib/
Sunitinib - API Impurities - Alentris Research Pvt. Ltd.
api impuritiessunitinibresearchpvtltd
https://www.genuinedrugs123.com/info/sunitinib-sutent-patient-information-leaflet-in-chinese
Sunitinib Sutent - Patient Information Leaflet in Chinese
Sunitinib Sutent - See Medication Guide as developed by the manufacturer, approved by the FDA, and translated in Chinese for Patient Use and Reference,...
patient information leafletsunitinibsutentchinese
https://pubmed.ncbi.nlm.nih.gov/25075067/
Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter...
Clinical outcome of the metastatic non-clear cell RCC patients with sunitinib treatment seemed to be worse than the historical data of clear cell RCC patients,...
for patients with
https://www.archivesofmedicalscience.com/Analysis-of-adverse-events-of-sunitinib-in-patients-treated-for-advanced-renal-cell,53493,0,2.html
Analysis of adverse events of sunitinib in patients treated for advanced renal cell carcinoma
Introduction : Treatment of the metastatic stage of renal cell carcinoma is specific because classical chemotherapy is not applicable here. The treatment is...
https://stage.cancerimagingarchive.net/tcia-citation/ctpred-sunitinib-pannet-pub/
CTPRED-SUNITINIB-PANNET-PUB - The Cancer Imaging Archive (TCIA)
cancer imagingsunitinibpannetpubarchive
https://pubmed.ncbi.nlm.nih.gov/21670421/
The vascular endothelial growth factor receptor inhibitor sunitinib causes a preeclampsia-like...
Angiogenesis inhibition is an established treatment for several tumor types. Unfortunately, this therapy is associated with adverse effects, including...
growth factor
https://www.clinicaltrialsarena.com/projects/sutent-sunitinib-malate-treatment-pancreatic-neuroendocrine-tumours/
Sutent (Sunitinib Malate) - Treatment for Pancreatic Neuroendocrine Tumours - Clinical Trials Arena
May 24, 2023 - Sutent (sunitinib malate) is an oral multikinase inhibitor which is indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine...
sunitinib malatetreatment forneuroendocrine tumoursclinical trialssutent
https://archive.cancerworld.net/tag/sunitinib/
sunitinib | Cancer World Archive
sunitinibcancerworldarchive